Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion.

Literature DB >> 15118974

5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion.

Brian G Feagan.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2004 PMID： 15118974 DOI： 10.1016/s1542-3565(04)00121-1

Source DB: PubMed Journal: Clin Gastroenterol Hepatol ISSN： 1542-3565 Impact factor: 11.382

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Guidelines for the management of inflammatory bowel disease in adults.

Authors: M J Carter; A J Lobo; S P L Travis
Journal: Gut Date: 2004-09 Impact factor: 23.059

2. Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.

Authors: Javier P Gisbert; María Chaparro; Fernando Gomollón
Journal: World J Gastroenterol Date: 2011-08-14 Impact factor: 5.742

3. Comparison of capsule endoscopy and magnetic resonance (MR) enteroclysis in suspected small bowel disease.

Authors: Stefan K Gölder; Andreas G Schreyer; Esther Endlicher; Stefan Feuerbach; Jürgen Schölmerich; Frank Kullmann; Johannes Seitz; Gerhard Rogler; Hans Herfarth
Journal: Int J Colorectal Dis Date: 2005-04-22 Impact factor: 2.571

Review 4. Advances in therapeutic approaches to ulcerative colitis and Crohn's disease.

Authors: Simon Travis
Journal: Curr Gastroenterol Rep Date: 2005-12

5. European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

Authors: S P L Travis; E F Stange; M Lémann; T Oresland; Y Chowers; A Forbes; G D'Haens; G Kitis; A Cortot; C Prantera; P Marteau; J-F Colombel; P Gionchetti; Y Bouhnik; E Tiret; J Kroesen; M Starlinger; N J Mortensen
Journal: Gut Date: 2006-03 Impact factor: 23.059

5-ASA therapy for active Crohn's disease: old friends, old data, and a new conclusion.

1. Guidelines for the management of inflammatory bowel disease in adults.

2. Common misconceptions about 5-aminosalicylates and thiopurines in inflammatory bowel disease.

3. Comparison of capsule endoscopy and magnetic resonance (MR) enteroclysis in suspected small bowel disease.

Review 4. Advances in therapeutic approaches to ulcerative colitis and Crohn's disease.

5. European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

6. Physicians' Perspectives on Cost, Safety, and Perceived Efficacy Determine Aminosalicylate Use in Crohn's Disease.

7. Medical management of Crohn's disease.

8. Searching for the delta: 5-aminosalicylic Acid therapy for Crohn's disease.

Review 9. Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?

10. Quality of care for patients with inflammatory bowel disease in East China.